-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
November 01, 2024 - Primary studies: Data were extracted into tables for the following fields: first author, year, study … KQ1 and KQ2 characteristics of included SRs (all low quality)
Author Year;
# of Studies;
Total N; … of the Evidence
8
Author Year;
# of Studies;
Total N; CKD
Stage;
Periodontal
Condition; … of the Evidence
9
Author Year;
Country;
Funding Source;
CKD Stage
Quality
Design;
Total … No meta-
3.3.2 Results, Key Question 4, Detailed Description of the Evidence
25
Author Year;
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - primary outcomes
3
Description of secondary outcome
Analysis Description of the pre-specified … or the year of study completion. … Description of the Identified Studies
Question 2. … Description of the Identified Studies
Question 2. … Description of the Identified Studies
Question 2.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
July 27, 2023 - Intervention RQs 1-4: Not applicable (description of harms
associated with anticoagulant use in the … Description of Included Studies
To efficiently describe eligible studies, the full text of each potentially … To describe eligible systematic reviews, a single team member will prepare a summary
including the author … , year, study design, number of study part... … To describe eligible systematic reviews, a single team member will prepare a summary including the author
-
effectivehealthcare-admin.ahrq.gov/products/diabetes-glucose-control/research
January 01, 2020 - Author Affiliations
Jodi B. Segal, M.D., M.P.H. a
Sydney M. Dy, M.D. b
E. … Results
Description of the Cohort
We received data on 1,234,540 individuals meeting the broad … Description of Individuals Using Exenatide by Treatment Period
In Table 1 is a description of the … Description of individuals with diabetes mellitus by date of first exenatide use
Covariates … Description of individuals with diabetes mellitus stratified by injectable medication use
Covariates
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Was there a clear description of the techniques used to identify the events?
5. … Was the description of the population adequate?
2. … Trials of rofecoxib vs NSAIDs
Author
year
Aspirin
permitted? … Trials of etoricoxib and lumiracoxib (Safety only)
Author
Year
Patient
masked? … Topical NSAIDs trials
External Validity
Author
Year
Patient
masked?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
July 01, 2010 - ...........................................................................................7
Author … Results
Description of the Cohort
We received data on 1,234,540 individuals meeting the broad criteria … Description of Individuals Using Exenatide by Treatment Period
In Table 1 is a description of the patients … Description of individuals with diabetes mellitus stratified by injectable medication use
Covariates … Description of individuals with diabetes mellitus stratified by injectable medication use (continued)
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research-appendix-c.xlsx
January 01, 2024 - Characteristics and outcomes of included systematic reviews
Author, Year Objectives/Aim Population Inclusion … of Participants, n Comparator Intervention Category Interventions Description Patient Safety Outcome … 2016–2017, 16.7% for the year 2017–2018, and 5.7% for the year 2018–2019. … Barriers, facilitators, and resources reported in primary studies
Author, Year Study Design Intervention … Author, Year Risk of Bias Judgment: Confounding Risk of Bias Judgment: Selection Risk of Bias Judgment
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c.xlsx
September 01, 2024 - Table C-1 Characteristics of included studies KQ 3 and KQ 5
First Author Last Name Year of Publication … KQ 5 Outcomes (Harms)
First Author Last Name Year of Publication Harm Outcomes
Lennon 2020 Of the 108 … Risk of Bias of Included Studies for KQ 5
First Author Last Name Year of Publication Is it clear in … TACIT for Included Studies for KQ 3 and KQ 5
First Author Last name Year of Publication 1.1 Did any … TACIT for Systematic Reviews in the CQ
First Author Last Name Year of publication 1.1 Did any funders
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
January 15, 2013 - Evidence Table
Study Description Intervention
Inclusion/Exclusion
Criteria/ Population Baseline … on a
protein-restricted diet and the
rest were on BH4.
97.7% of the early diagnosed
Study Description … Analysis of lifetime Phe data
showed that Phe levels at
ages 4, 5, and 6 accounted for
Study Description … within therapeutic targets and
a decrease in the values above
target…, and decreased the
Study Description … No studies identified
Study Description Intervention
Inclusion/Exclusion
Criteria/ Population
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
July 01, 2023 - Timing Original studies published from
2019 onwards, the year of the
search done for the MHS III report … reviewed by a single team member to confirm eligibility and prepare a summary of the study,
including author … , year, study design, number of study participants, and main findings relevant to
the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including
the author … , year, number of studies by study design, and main findings relevant to each of our
review questions
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
October 29, 2021 - high-utilizers-health-care/research
Published Online: October 29, 2021
2
Summary of Peer Reviewer Comments and Author … Changes included improving the description of the
inclusion/exclusion criteria in methods; more clearly … We
expanded our description of the realist review literature rigor assessment to better
explain how … high-utilizers-health-care/research
Published Online: October 29, 2021
5
Public Comments and Author … stakeholder interpretation of LCA and
k-means outputs, and demonstrates significant differences in 1-year
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/economic-evaluation-tools_research.pdf
October 01, 2012 - Did the authors provide a detailed description of the
alternatives?
a. … Source and description of cost valuation
17. … Description of comparator programs
6. Boundaries of the analysis
7. Time horizon
8. … Description of model used
12. Modeling assumptions
13. Diagram of event pathway
14. … Did the author(s) explicitly discuss direction and magnitude of potential biases?
15.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
May 26, 2016 - Comment Response
Peer Reviewer
#1
Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description
of the findings to the beginning of the result … We have included a
description of and a citation for the DECIDE study in the
“Future Areas for Research … Peer Reviewer
#2
Background The Background was thorough in its description of the clinical
problem … Peer Reviewer
#4
Methods “Systematic review” may not be the most appropriate description of
this
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
January 01, 2024 - Overview of the included studies for PSP 1
Author, Year
Study Design
Clinical Setting
Country … Overview of the included reviews for PSP 2
Author, Year
Study Design
Clinical Setting
Country … Moderate
22 Making Healthcare Safer IV – Anticoagulant Use
Author, Year
Study Design … Overview of the studies of PSP 1 on care transitions
Author, Year
Study
Design Objectives
Study … Risk of bias assessment for nonrandomized studies*
Author,
Year Confounding
Patient
Selection
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-surgical-report-cards/protocol
September 01, 2023 - A 1998 study estimated that over 40-50 million operations are performed in the USA each year in hospital … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of our review questions
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
July 01, 2023 - • No outcome of interest
Timing Original studies published from
2011 onwards, the year of the … reviewed by a single team member to confirm eligibility and prepare a summary of
the study, including author … , year, study design, number of study participants, and main
findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary
including the author … , year, number of studies by study design, and main findings
relevant to each of our review questions
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-active-infection/protocol
September 01, 2023 - Eligibility Criteria for Studies of Effectiveness
Literature Searches for Studies of Effectiveness
Description … Description of Included Studies
To efficiently describe eligible studies, the full … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … To describe eligible systematic reviews, a single team member will prepare a summary including the author … For Review Question 8, we will list the source of each relevant toolkit along with a 1-2 sentence description
-
effectivehealthcare-admin.ahrq.gov/products/mhs4-patient-family-engagement/protocol
September 01, 2023 - or engagement levels only No outcome of interest Timing Original studies published since 2019, the year … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings relevant to each of our review … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of our review questions
-
effectivehealthcare-admin.ahrq.gov/products/high-risk-drugs/protocol
September 01, 2023 - We will search PubMed published since 2019 (as MHS III searches were run through 2018), the year … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings for each of the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of the rapid response questions
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/autoimmune-disease-rapid-research.pdf
November 01, 2024 - Characteristics and findings of the included systematic reviews
Author
Year;
Disease;
Dental Intervention … Study design and population characteristics of the included primary studies
Study Type Author
Year … Summary of findings in the included primary studies
Study
Type
Author
Year
Country
Study … List of excluded studies along with exclusion reasons
Author
Year
Title DOI Exclusion Reason
Silva … Risk of bias assessment evaluated by RoB2 for RCTs
RCT by Patient
Condition RCT Author and Year
Risk